Academic Journals Database
Disseminating quality controlled scientific knowledge

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma

ADD TO MY LIST
 
Author(s): Tezval Hossein | Merseburger Axel | Matuschek Ira | Machtens Stefan | Kuczyk Markus | Serth Jürgen

Journal: BMC Urology
ISSN 1471-2490

Volume: 8;
Issue: 1;
Start page: 12;
Date: 2008;
Original page

ABSTRACT
Abstract Background Epigenetic silencing of RAS association family 1A (RASSF1A) tumor suppressor gene occurs in various histological subtypes of renal cell carcinoma (RCC) but RASSF1A protein expression in clear cell RCC as well as a possible correlation with clinicopathological parameters of patients has not been analyzed at yet. Methods 318 primary clear cell carcinomas were analyzed using tissue microarray analysis and immunohistochemistry. Survival analysis was carried out for 187 patients considering a follow-up period of 2–240 month. Results Expression of RASSF1A was found to be significantly decreased in tumoral cells when compared to normal tubular epithelial cells. RASSF1A immunopositivity was significantly associated with pT stage, group stage and histological grade of tumors and showed a tendency for impaired survival in Kaplan-Meier analysis. Conclusion While most tumors demonstrate a loss of RASSF1A protein, a subset of tumors was identified to exhibit substantial RASSF1A protein expression and show increased tumor progression. Thus RCC tumorigenesis without depletion of RASSF1A may be associated with an adverse clinical outcome.
RPA Switzerland

Robotic Process Automation Switzerland

    

Tango Jona
Tangokurs Rapperswil-Jona